Experimental PET Tracer Maps Cellular Stress After Ischemic Stroke
Published in Brain/Neurology, Ischemia, Journals, Scanners and Imaging.
Publication date: October 9, 2026.
The Society of Nuclear Medicine and Molecular Imaging highlighted an experimental PET tracer for studying ischemic stroke in its October 9 research briefing. The tracer targets erythropoietin receptors, which participate in cellular responses to low oxygen.
According to the society’s summary of the Journal of Nuclear Medicine study, the tracer accumulated in injured brain regions in two animal models of ischemic stroke. Researchers also tested human stroke tissue, where binding was especially evident around the most severely damaged areas.
The approach offers a research window into cellular stress surrounding a stroke injury. Its potential value lies in investigating biological responses beyond the central damaged region; the reported findings do not establish that this signal can identify salvageable tissue or guide treatment decisions.
Animal imaging and binding tests on human tissue are distinct from a clinical trial of PET scanning in stroke patients. Diagnostic accuracy, patient safety, and practical effects on care therefore require further evaluation before clinical use can be inferred.
Sources: SNMMI research briefing, October 9, 2026; Journal of Nuclear Medicine study.